Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hubbard

Showing results (541-550 of 562) with videos related to

Pageof 57
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Cancer|April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilotAmye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Plos One|July 16, 2011
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.
Psychiatric Genetics|June 10, 2014
Summaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17-21 October 2013: state of the fieldHilary Akpudo, Branko Aleksic, Anna Alkelai, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance TaskforceHarriet M Kluger, Hussein A Tawbi, Maria L Ascierto, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
Human Gene Therapy|September 20, 2017
Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay-Sachs DiseaseHeather L Gray-Edwards, Ashley N Randle, Stacy A Maitland, et al.
ESMO Open|August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
The Lancet. Oncology|January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyMark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Cancers|August 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD DatabaseFang-Shu Ou, Daniel H Ahn, Jesse G Dixon, et al.
Pageof 57

Showing results (541-550 of 562) with videos related to

Sort By:
Pageof 57
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2010
Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host diseaseSydney X Lu, Amanda M Holland, Il-Kang Na, et al.
Cancer|April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilotAmye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Plos One|July 16, 2011
Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantationSydney X Lu, Lucy W Kappel, Anne-Marie Charbonneau-Allard, et al.
Psychiatric Genetics|June 10, 2014
Summaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17-21 October 2013: state of the fieldHilary Akpudo, Branko Aleksic, Anna Alkelai, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance TaskforceHarriet M Kluger, Hussein A Tawbi, Maria L Ascierto, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
Human Gene Therapy|September 20, 2017
Adeno-Associated Virus Gene Therapy in a Sheep Model of Tay-Sachs DiseaseHeather L Gray-Edwards, Ashley N Randle, Stacy A Maitland, et al.
ESMO Open|August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
The Lancet. Oncology|January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyMark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Cancers|August 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD DatabaseFang-Shu Ou, Daniel H Ahn, Jesse G Dixon, et al.
Pageof 57